Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

NCT04913272 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

630

Enrollment

INDUSTRY

Sponsor class

Stopped Logistics, company reorganization

Conditions

Chronic Kidney Disease stage4

Interventions

DRUG: US-APR2020
DRUG: Placebo

Sponsor

Kibow Pharma